These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21794800)

  • 21. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
    Tant L; Steinfeld S
    Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis.
    von Delwig A; Locke J; Robinson JH; Ng WF
    Arthritis Rheum; 2010 Jan; 62(1):143-9. PubMed ID: 20039419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
    Cantaert T; Coucke P; De Rycke L; Veys EM; De Keyser F; Baeten D
    Ann Rheum Dis; 2005 Sep; 64(9):1316-20. PubMed ID: 15760928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody.
    Ordóñez A; Yélamos J; Pedersen S; Miñano A; Conesa-Zamora P; Kristensen SR; Stender MT; Thorlacius-Ussing O; Martínez-Martínez I; Vicente V; Corral J
    Thromb Haemost; 2010 Dec; 104(6):1143-9. PubMed ID: 20838745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia.
    van de Stadt LA; van der Horst AR; de Koning MH; Bos WH; Wolbink GJ; van de Stadt RJ; Pruijn GJ; Dijkmans BA; van Schaardenburg D; Hamann D
    Ann Rheum Dis; 2011 Jan; 70(1):128-33. PubMed ID: 21062853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
    Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF
    Ann Rheum Dis; 2011 Sep; 70(9):1575-80. PubMed ID: 21571731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
    van Venrooij WJ; Zendman AJ; Pruijn GJ
    Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
    Verpoort KN; Cheung K; Ioan-Facsinay A; van der Helm-van Mil AH; de Vries-Bouwstra JK; Allaart CF; Drijfhout JW; de Vries RR; Breedveld FC; Huizinga TW; Pruijn GJ; Toes RE
    Arthritis Rheum; 2007 Dec; 56(12):3949-52. PubMed ID: 18050209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    de Man YA; Bakker-Jonges LE; Goorbergh CM; Tillemans SP; Hooijkaas H; Hazes JM; Dolhain RJ
    Ann Rheum Dis; 2010 Feb; 69(2):420-3. PubMed ID: 19282308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
    Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
    Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticitrullin antibodies--modern markers of rheumatoid arthritis].
    Shilkina NP; Luzinova MS; Vinogradov AA
    Ter Arkh; 2011; 83(1):70-5. PubMed ID: 21446207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
    Klaasen R; Cantaert T; Wijbrandts CA; Teitsma C; Gerlag DM; Out TA; de Nooijer MJ; Baeten D; Tak PP
    Rheumatology (Oxford); 2011 Aug; 50(8):1487-93. PubMed ID: 21454308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.